Dorota Pach

1.3k total citations
87 papers, 898 citations indexed

About

Dorota Pach is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Dorota Pach has authored 87 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Epidemiology and 20 papers in Molecular Biology. Recurrent topics in Dorota Pach's work include Neuroendocrine Tumor Research Advances (20 papers), Heme Oxygenase-1 and Carbon Monoxide (13 papers) and Neuroblastoma Research and Treatments (12 papers). Dorota Pach is often cited by papers focused on Neuroendocrine Tumor Research Advances (20 papers), Heme Oxygenase-1 and Carbon Monoxide (13 papers) and Neuroblastoma Research and Treatments (12 papers). Dorota Pach collaborates with scholars based in Poland, Germany and Austria. Dorota Pach's co-authors include Alicja Hubalewska‐Dydejczyk, Anna Sowa‐Staszczak, Renata Mikołajczak, Agnieszka Stefańska, Monika Tomaszuk, Aleksandra Gilis‐Januszewska, Jan Kulig, Bohdan Huszno, Elwira Przybylik‐Mazurek and Leszek Satora and has published in prestigious journals such as PLoS ONE, Medicine and Radiotherapy and Oncology.

In The Last Decade

Dorota Pach

77 papers receiving 867 citations

Peers

Dorota Pach
Dorota Pach
Citations per year, relative to Dorota Pach Dorota Pach (= 1×) peers Yujing Zhang

Countries citing papers authored by Dorota Pach

Since Specialization
Citations

This map shows the geographic impact of Dorota Pach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorota Pach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorota Pach more than expected).

Fields of papers citing papers by Dorota Pach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorota Pach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorota Pach. The network helps show where Dorota Pach may publish in the future.

Co-authorship network of co-authors of Dorota Pach

This figure shows the co-authorship network connecting the top 25 collaborators of Dorota Pach. A scholar is included among the top collaborators of Dorota Pach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorota Pach. Dorota Pach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pach, Dorota, et al.. (2024). Life-threatening amiodarone-induced thyrotoxicosis – Personalized approach to radical treatment. Heliyon. 10(14). e34850–e34850.
2.
Kamińska, Magdalena, Monika Buziak‐Bereza, Dorota Pach, et al.. (2023). A patient with advanced breast cancer and hyperthyroidism associated with struma ovarii. Endokrynologia Polska. 74(1). 115–116. 1 indexed citations
3.
Pach, Dorota, et al.. (2021). Graves’ disease and exophthalmos — a mask for meningioma. Endokrynologia Polska. 72(2). 179–180. 2 indexed citations
4.
Gilis‐Januszewska, Aleksandra, et al.. (2017). Pituitary insufficiency following traumatic thoracic injury in an adolescent male patient. Medicine. 96(44). e8406–e8406. 1 indexed citations
5.
Trofimiuk–Müldner, Małgorzata, Dorota Pach, Agnieszka Kiełtyka, et al.. (2017). Epidemiologia nowotworów neuroendokrynnych układu pokarmowego w Krakowie i powiecie krakowskim w latach 2007-2011.. Endokrynologia Polska. 68(1). 42–46. 8 indexed citations
6.
Bar‐Andziak, Ewa, Tomasz Bednarczuk, Monika Buziak‐Bereza, et al.. (2017). Reference Values for TSH and Free Thyroid Hormones in Healthy Pregnant Women in Poland: A Prospective, Multicenter Study. European Thyroid Journal. 6(2). 82–88. 23 indexed citations
7.
Pach, Dorota, Anna Sowa‐Staszczak, Agnieszka Stefańska, et al.. (2013). Glucagon-Like Peptide-1 Receptor Imaging with [Lys 40 (Ahx-HYNIC- 99 m Tc/EDDA)NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report. International Journal of Endocrinology. 2013. 1–6. 17 indexed citations
8.
Sowa‐Staszczak, Anna, Dorota Pach, Renata Mikołajczak, et al.. (2012). Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. European Journal of Nuclear Medicine and Molecular Imaging. 40(4). 524–531. 90 indexed citations
9.
Przybylik‐Mazurek, Elwira, Alicja Hubalewska‐Dydejczyk, Anna Skalniak, et al.. (2012). Dietary patterns as risk factors of differentiated thyroid carcinoma. Postępy Higieny i Medycyny Doświadczalnej. 66. 11–15. 16 indexed citations
10.
Sowa‐Staszczak, Anna, Robert Chrzan, Dorota Pach, et al.. (2012). Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?. Clinical Imaging. 36(4). 360–364. 8 indexed citations
11.
Sowa‐Staszczak, Anna, Dorota Pach, Agnieszka Stefańska, et al.. (2011). Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours?. Nuclear Medicine Review. 14(2). 73–78. 8 indexed citations
12.
Pach, Dorota, Anna Sowa‐Staszczak, Jolanta Kunikowska, et al.. (2011). Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET. Radiotherapy and Oncology. 102(1). 45–50. 34 indexed citations
13.
Hubalewska‐Dydejczyk, Alicja, P. Szybiński, Małgorzata Trofimiuk, et al.. (2008). Expression of the somatostatin receptors (SSTRs) in patients with gastro-pancreatic neuroendocrine tumours (GEP-NET) and medullary thyroid cancers (MTC). 16(17). 3949–54. 1 indexed citations
14.
Szafraniec, Krystyna, et al.. (2006). [Prevalence of the metabolic syndrome and its components in adult inhabitants of Krakow].. PubMed. 63(9). 733–7. 5 indexed citations
15.
Satora, Leszek, et al.. (2006). Panther cap Amanita pantherina poisoning case report and review. Toxicon. 47(5). 605–607. 28 indexed citations
16.
Hubalewska‐Dydejczyk, Alicja, Katarzyna Fröss‐Baron, Renata Mikołajczak, et al.. (2006). 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years’ experience. European Journal of Nuclear Medicine and Molecular Imaging. 33(10). 1123–1133. 82 indexed citations
17.
Kolarzyk, Emilia, et al.. (2005). Nutritional status of the opiate dependent persons after 4 years of methadone maintenance treatment.. PubMed. 62(6). 373–7. 27 indexed citations
18.
Kolarzyk, Emilia, et al.. (2005). Assessment of daily nutrition ratios of opiate-dependent persons before and after 4 years of methadone maintenance treatment.. PubMed. 62(6). 368–72. 21 indexed citations
19.
Kolarzyk, Emilia, et al.. (2005). The changes in taste preferences during 4 years period of methadone maintenance treatment.. PubMed. 62(6). 378–81. 12 indexed citations
20.
Pach, J, et al.. (2001). Usefulness of rest and forced perfusion scintigraphy (SPECT) to evaluate cardiotoxicity in acute carbon monoxide poisoning.. PubMed. 58(4). 297–300. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026